FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
16 letters match. Newest first.
-
DrugsPro Numb Tattoo Numbing Spray, LLC
FDA cited Pro Numb Tattoo Numbing Spray for selling unapproved, misbranded numbing drugs and manufacturing quality failures after a November 2025 inspection.
High risk -
DrugsSinsin Pharmaceutical Co., Ltd.
FDA warned Sinsin Pharmaceutical that two Korean topical pain relievers sold in the US are unapproved and misbranded drugs.
High risk -
DrugsDynamic Blending Specialists, Inc.
FDA cited Dynamic Blending Specialists for manufacturing failures in OTC drugs and an unapproved, misbranded oral antiseptic.
High risk -
DrugsAmish Origins Management, LLC
FDA warned Amish Origins over manufacturing quality failures and unapproved or misbranded OTC pain relief and lip balm products.
High risk -
DrugsAmazon.com, Inc.
Amazon sold unapproved numbing creams for tattoos and cosmetic procedures, FDA says.
High risk -
DrugsPMS4PMS, LLC
FDA warns PMS4PMS of Clarence, NY, over CGMP failures and an unapproved menstrual cramp relief cream.
High risk -
DrugsTKTX Numbing Cream USA
FDA warned TKTX Numbing Cream USA that its lidocaine numbing creams are unapproved and misbranded new drugs.
High risk -
DrugsSombra Cosmetics, Inc.
FDA warned Sombra Cosmetics of OTC drug CGMP violations, including inadequate water controls and component testing.
High risk -
DrugsLittle Moon Essentials, LLC
FDA warns Little Moon Essentials over CGMP failures and unapproved topical analgesic drugs made in Dania Beach, Florida.
High risk -
DrugsSky Bank Media, LLC dba Painless Tattoo Cream Co.
FDA warned Painless Tattoo Cream Co. that its numbing cream and spray are unapproved new drugs with excess lidocaine.
High risk -
DrugsTKTX Company
TKTX Company sells unapproved, misbranded lidocaine numbing creams online at illegal concentrations for cosmetic procedures.
High risk -
DrugsIndelicare DBA INKEEZE
FDA warns Indelicare that its INKEEZE lidocaine numbing gel, spray and foam soap are unapproved new drugs sold outside OTC limits.
High risk -
DrugsOrchid Lifesciences
FDA warns Orchid Lifesciences over over-the-counter drug testing gaps and weak quality unit.
High risk -
DrugsSkyless, LLC
FDA cited Skyless, LLC for CGMP failures and for selling three X-PASMO topical analgesic ointments as unapproved and misbranded drugs.
High risk -
DrugsCustom Research Labs Inc.
FDA warned Custom Research Labs Inc. about manufacturing-practice violations and unapproved, misbranded OTC drugs, including hand sanitizers and topical analgesics.
High risk -
DrugsLaboratorio Pharma International SRL
FDA warns Laboratorio Pharma International over CGMP failures, unapproved GELAZUL, misbranding, and incomplete beta-lactam separation.
High risk